CVintra in replicate designs (→ 2 IBDs) [General Sta­tis­tics]

posted by Helmut Homepage – Vienna, Austria, 2021-01-05 11:38 (760 d 01:35 ago) – Posting: # 22176
Views: 1,334

Hi clinicalservices,

❝ We are planning to conduct Steady State study having study design as- T1, T2, R, R.

❝ What should be our approach for calculation of Intra subject variability for such study design.

What’s the purpose of the study – a pilot study to select either T1 or T2 for a pivotal study?

Dif-tor heh smusma 🖖🏼 Довге життя Україна! [image]
Helmut Schütz

The quality of responses received is directly proportional to the quality of the question asked. 🚮
Science Quotes

Complete thread:

UA Flag
 Admin contact
22,478 posts in 4,708 threads, 1,604 registered users;
15 visitors (0 registered, 15 guests [including 11 identified bots]).
Forum time: 13:13 CET (Europe/Vienna)

If you don’t like something change it;
if you can’t change it, change the way you think about it.    Mary Engelbreit

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz